Yuman Fong, MD, discusses the evolution of colorectal liver metastases management from historical neglect to multimodal ...

The CEO of ModeX Therapeutics discusses MDX2003, a groundbreaking tetraspecific therapy that promises enhanced efficacy and ...

The dyad model fosters collaboration between academic specialists and community oncologists, ensuring seamless patient care ...

Michael David Chuong, MD, discusses how SBRT has become a leading option for treating patients with colorectal liver ...

Gastrointestinal (GI) Cancers Symposium, Dani Castillo, MD, medical oncologist, City of Hope, shared new research titled, “Impact of metastatic sites and Lauren subtype on survival outcomes of ...

Racial and ethnic disparities in pancreatic cancer treatment and survival persist, with minority groups experiencing lower ...

With the debut of TrumpRx.gov and other moves, the administration is steering the nation toward a market-driven, “America ...

With Johnson & Johnson’s participation, 15 of 17 companies contacted by the administration over the summer have now signed on ...

Ever-smokers receiving immunotherapy for gastric and esophageal cancers showed better survival outcomes but higher relapse ...

Zanidatamab shows promise in extending survival for patients with HER2-positive biliary tract cancer, marking a significant ...

Delays in breast cancer diagnosis and treatment highlight the need for improved human capital investment in health care ...

Experts explore HER2 mutations and the critical role of comprehensive molecular profiling in optimizing treatment for ...